Phase I-II Trial of Prone Accelerated Intensity Modulated Radiation Therapy to the Breast to Optimally Spare Normal Tissue
- 1 June 2007
- journal article
- breast cancer
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 25 (16), 2236-2242
- https://doi.org/10.1200/jco.2006.09.1041
Abstract
Purpose: To report the clinical feasibility of a trial of accelerated whole-breast intensity modulated radiotherapy, with the patient in prone position, optimally to spare the heart and lung. Patients and Methods: Patients with stages I or II breast cancer, excised by breast conserving surgery with negative margins, were eligible for this institutional review board–approved prospective trial. Computed tomography simulation was performed with the patient prone on a dedicated breast board, in the exact position used for treatment. A dose of 40.5 Gy, delivered at 2.7 Gy in 15 fractions, was prescribed to the index breast with an additional concomitant boost of 0.5 Gy delivered to the tumor bed, for a total dose of 48 Gy to the lumpectomy site. Physics constraints consisted of limiting ≤ 5% of the heart volume to receive ≥ 18 Gy and ≤ 10% of the ipsilateral lung volume to receive ≥ 20 Gy. Results: Between September 2003 and August 2005, 91 patients were enrolled on the study. Median length of follow-up was 12 months (range, 1 to 28 months). In all patients the technique was feasible and heart and lung sparing was achieved as prescribed by the protocol. Acute toxicities consisting mostly of reversible grades 1-2 skin dermatitis (67%) and fatigue (18%) occurred in 75 patients. One patient sustained a regional recurrence rapidly followed by distant metastases. Conclusion: Accelerated whole breast intensity modulated radiotherapy in the prone position is feasible and it permits a drastic reduction in the volume of lung and heart tissue exposed to significant radiation.This publication has 61 references indexed in Scilit:
- A cost comparison analysis of partial versus whole-breast irradiation after breast-conserving surgery for early-stage breast cancerInternational Journal of Radiation Oncology*Biology*Physics, 2005
- Novel Approaches to Postoperative Radiation Therapy as Part of Breast-Conserving Therapy for Early-Stage Breast CancerClinical Breast Cancer, 2003
- Randomized Trial of Breast Irradiation Schedules After Lumpectomy for Women With Lymph Node-Negative Breast CancerJNCI Journal of the National Cancer Institute, 2002
- Radiation therapy and patient age in the survival from early-stage breast cancerInternational Journal of Radiation Oncology*Biology*Physics, 1999
- Compliance with consensus recommendations for the treatment of early stage breast carcinoma in elderly womenCancer, 1999
- Time-dose factors in radiotherapy: a review of the human dataRadiotherapy and Oncology, 1990
- The use of a specific hypofractionated radiation therapy reg imen versus classical fractionation in the treatment of breast cancer: A randomized study of 230 patientsInternational Journal of Radiation Oncology*Biology*Physics, 1990
- The linear-quadratic formula and progress in fractionated radiotherapyThe British Journal of Radiology, 1989
- Response of human tumor cell lines in vitro to fractionated irradiationInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Dose fractionation, dose rate and iso-effect relationships for normal tissue responsesInternational Journal of Radiation Oncology*Biology*Physics, 1982